Cuirass Fitting Study - Time for Mounting and Ventilation

Sponsor
Rigshospitalet, Denmark (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT06136858
Collaborator
(none)
60
1

Study Details

Study Description

Brief Summary

Non-invasive biphasic cuirass ventilation (BCV) has recently been described for ENT surgery (ref 1-2). The clinical experience is however still sparse and further study is required.

The purpose of the study is to descibe 1) mounting time and fitting of the cuirass shell on voluntary participants and 2) time to visible ventilation

Condition or Disease Intervention/Treatment Phase
  • Device: Cuirass ventilation

Detailed Description

The purpose of this study is to evaluate the the fitting of the Cuirass shell on healthy volunteers. Even though there is growing knowledge of Cuirass ventilation in anaesthesia, (ref. 1-2) there is sparse experiences with the time required for fitting the Cuirass shell and the time to start of ventilation. This knowledge is paramount before even discussing the potential use of Cuirass ventilation in acute settings in the future.

In addition to the invitation to the Copenhagen Airway Management course in Copenhagen Denmark on 30th of November 2023, all participants have been invited an has accepted to participate in the study.

In total 60 to 65 participants will all have the Cuirass shell fitted and will be awake ventilated with Biphasic Cuirass Ventilation. All participants have given consent to being video filmed.

The study will register the time it takes to fit the Cuirass shell and the time before visible ventilation is obtained.

All participants will be in their habitual state i.e..no sedation is required since the product was originally designed for home use in awake patients.

Study Design

Study Type:
Observational
Anticipated Enrollment :
60 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Cuirass Shell Fitting and Time to Visible Ventilation in Healthy Volunteers - an Observational Study.
Anticipated Study Start Date :
Nov 30, 2023
Anticipated Primary Completion Date :
Nov 30, 2023
Anticipated Study Completion Date :
Nov 30, 2023

Arms and Interventions

Arm Intervention/Treatment
healthy volunteers

participants of the Airway management Course in Copenhagen Denmark 2023

Device: Cuirass ventilation
We will fit the Cuirass Shell and start Biphasic Cuirass Ventilation on all participants.

Outcome Measures

Primary Outcome Measures

  1. The primary end point of the study is to evaluate the number of participants who are fitted with the Cuirass shell and have visible ventilation in a two liters breathing bag within three minutes. [15 minuttes]

    Timing of the above

Secondary Outcome Measures

  1. Mean time for fitting of the cuirass shell and start of visible ventilation and fraction of participants who can be ventilated within one minute and within two minuttes [15 minuttes]

    timing of the above

Other Outcome Measures

  1. qualitative assessment [15 minuttes]

    During Cuirass ventilation did you experience discomfort on a scale from 1 to 10, Pain on a scale from 1 to10 And if Cuirass ventilation was the main driver of the partipants ventilation

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • participants of the airway course
Exclusion Criteria:
  • Recent surgery in thoracic or abdominal compartments

  • participants with pace-maker

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rigshopitalet Copenhagen Oesterbro Denmark 2100

Sponsors and Collaborators

  • Rigshospitalet, Denmark

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jakob Friis Schmidt, Staff specialist anaesthesiology MD phD, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT06136858
Other Study ID Numbers:
  • The Cuirass Fitting Trial
First Posted:
Nov 18, 2023
Last Update Posted:
Nov 18, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 18, 2023